Leading the shift toward precision therapy and preventive cardiology.
The global market for Cardiovascular Health Drugs is witnessing an unprecedented evolution. As cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, the demand for sophisticated pharmaceutical interventions—ranging from traditional anti-hypertensives to advanced drug-eluting embolic microspheres—has surged. Currently, the industry is transitioning from a "one-size-fits-all" approach to Precision Cardiology, utilizing AI-driven diagnostics and targeted drug delivery systems to improve patient outcomes.
The global cardiovascular drugs market size was valued at USD 155.6 billion in 2022 and is projected to reach USD 230 billion by 2030, driven by aging populations and lifestyle-related risks.
Emphasis is shifting toward high-bioavailability formulations, nanomedicine, and microsphere technology for targeted embolization in complex vascular treatments.
Global pharmaceutical buyers are increasingly seeking vertically integrated manufacturers that can provide stable API supplies alongside finished dosage forms under strict GMP compliance.
In the realm of preventive cardiovascular care, natural polyphenols have taken center stage. Our FDA-compliant Anthocyanin Softgels are designed using a specialized extraction process that preserves the antioxidant integrity of the compounds. These softgels support endothelial function and help maintain healthy blood pressure levels, making them a staple for healthcare providers focusing on long-term heart maintenance.
From modern hospitals in Dubai to pharmaceutical distributors in Mumbai.
Provision of Drug-Eluting Embolic Microspheres for Uterine Artery Embolization (UAE) and other interventional radiology procedures where precision is critical.
Supplying Magnesium Tablets and cardiovascular supplements that meet the growing consumer demand for heart-healthy daily nutrition and mineral synergy.
Recognizing the cross-over in pharmaceutical chemistry, our Calcium Gluconate Solutions provide essential cardiovascular and metabolic support for livestock and poultry.
Magnesium is vital for maintaining a steady heart rhythm. Our Professional Grade Magnesium Tablets are formulated for sports nutrition and daily cardiovascular health management. As a leading manufacturer, we ensure each batch provides consistent bioavailability, aiding in muscle relaxation and preventing vascular calcification.
For global importers, we provide full supply chain transparency and batch consistency, ensuring that your local brand maintains the highest health standards.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is a premier entity engaged in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and chemicals.
QLU is headquartered in Xian, China, with 3 production bases in Shandong, Zhejiang, and Hebei separately. These facilities have many years of experience in the production of APIs, vitamins, and chemical products. Our facilities are certified with GMP, ISO, FAMI-QS, KOSHER, and HALAL.
We have complete control over our product development, design, and manufacturing processes, thanks to our advanced equipment, methods, and inspection facilities.
In the ever-changing pharmaceutical industry, the spirit of QLU is characterized by flexibility and adaptability. We embrace emerging technologies, actively adopt new scientific advancements, and continuously evolve to meet the needs of patients and healthcare providers.
With key competencies in pharmaceuticals and food health, Richer Pharma has established extensive business networks around the world. We have Strategic Marketing Partners in Mumbai and Dubai, ready to provide the best products and localized services.
Focus on pharmaceutical products, food ingredients, and vitamins.
Engaged in marketing of APIs, ingredients, vitamins, and intermediates.
Transitioned into the integrated production and marketing of APIs and chemical products.
Devoted to the comprehensive development, production, and marketing of all kinds of APIs and chemicals globally.
Leveraging massive industrial clusters in Shandong and Zhejiang to provide high-quality cardiovascular drugs at competitive global prices.
Continuous investment in "AI+Pharma" to optimize synthetic routes and improve the purity of active ingredients for better heart health results.
Our production bases adhere to international standards (GMP, ISO), ensuring that every batch exported meets the rigorous demands of the global market.
QLU Health
